Cargando…
Polyethyleneimine-treated polyacrylonitrile membrane hemofilter for critically ill patients receiving anticoagulant-free prolonged intermittent renal replacement therapy: a single-center, prospective, self-controlled pilot study
BACKGROUND: Critically ill patients requiring renal replacement therapy (RRT) are at risk of disease-related bleeding. Systemic heparinization should be avoided. AN69ST, a polyethyleneimine-treated polyacrylonitrile (AN69) membrane hemofilter, can be primed with heparin, improving its local anticoag...
Autores principales: | Su, Tao, Jin, Qizhuang, Liu, Zhongyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493884/ https://www.ncbi.nlm.nih.gov/pubmed/28666474 http://dx.doi.org/10.1186/s12882-017-0627-1 |
Ejemplares similares
-
Comparison of the cytokine adsorption ability in continuous renal replacement therapy using polyethyleneimine-coated polyacrylonitrile (AN69ST) or polymethylmethacrylate (PMMA) hemofilters: a pilot single-center open-label randomized control trial
por: Nakamura, Yoshihiko, et al.
Publicado: (2023) -
Effect of Continuous Renal Replacement Therapy with the oXiris Hemofilter on Critically Ill Patients: A Narrative Review
por: Li, Yupei, et al.
Publicado: (2022) -
First Reported Use of Highly Adsorptive Hemofilter in Critically Ill COVID-19 Patients in the USA
por: Padala, Sandeep Anand, et al.
Publicado: (2020) -
1282. Ceftolozane/Tazobactam Use in Critically Ill Patients Receiving Intermittent or Continuous Renal Replacement Therapy
por: Henry, Molly, et al.
Publicado: (2021) -
Continuous renal replacement therapy using a cellulose triacetate hemofilter for severe coronavirus disease
por: Takahashi, Kanako, et al.
Publicado: (2022)